BioMarin Pharmaceutical (BMRN) Interest Coverage Ratio: History & Chart

BioMarin Pharmaceutical Inc.(BMRN)

Biotechnology · San Rafael, CA

$56.22-1.32 (-2.29%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage disorder, and Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for individuals with MPS VI. Another notable offering is Kuvan, a unique synthetic oral version of 6R-BH4, prescribed for phenylketonuria (PKU), an inherited metabolic condition. Further expanding its product portfolio, BioMarin provides Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme administered via subcutaneous injection to lower blood Phe levels. Also available are Brineura, a recombinant human tripeptidyl peptidase 1 used in treating ceroid lipofuscinosis type 2, a variant of Batten disease; Voxzogo, a daily injectable c-type natriuretic peptide analog for achondroplasia; and Aldurazyme, a refined protein mirroring the naturally occurring human enzyme alpha-L-iduronidase. Beyond its established products, BioMarin has a robust development pipeline. This includes valoctocogene roxaparvovec, an adeno-associated virus vector undergoing Phase III clinical trials for severe hemophilia A. Additionally, BMN 307, an AAV5-mediated gene therapy, is in Phase 1/2 trials, aiming to normalize blood phenylalanine levels in PKU patients, while BMN 255 is also in Phase 1/2 trials for primary hyperoxaluria. Its clientele spans specialty pharmacies, hospitals, international government health bodies, and a network of distributors and pharmaceutical wholesalers. These services reach patients and healthcare providers across the United States, Europe, Latin America, and other global markets. BioMarin maintains strategic licensing and collaborative alliances with partners such as Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. Established in 1996, the company's corporate headquarters are located in San Rafael, California.

San Rafael, CA

3,221 employees

www.biomarin.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Alexander Hardy

View full financials

BMRN Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

48.95x

INTEREST COVERAGE RATIO AVG TTM

24.85x

INTEREST COVERAGE RATIO AVG 3Y

23.88x

INTEREST COVERAGE RATIO AVG 5Y

15.73x

INTEREST COVERAGE RATIO AVG 10Y

3.56x

INTEREST COVERAGE RATIO AVG 15Y

-2.68x

INTEREST COVERAGE RATIO AVG 20Y

-2.48x

CURRENT VS TTM AVG

+96.99%

CURRENT VS 3Y AVG

+104.94%

CURRENT VS 5Y AVG

+211.19%

CURRENT VS 10Y AVG

+1275.49%

CURRENT VS 15Y AVG

+1929.14%

CURRENT VS 20Y AVG

+2072.48%

SECTOR MEDIAN · HEALTHCARE

-6.38x

median of 528 covered companies

CURRENT VS SECTOR MEDIAN

+867.84%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
BioMarin Pharmaceutical Inc. (BMRN)	$10.87B	48.95x	24.85x	23.88x	15.73x
The Cooper Companies, Inc. (COO)vs ›	$11.01B	6.83x	6.50x	6.73x	9.55x
Universal Health Services, Inc. (UHS)vs ›	$10.72B	12.68x	10.82x	8.80x	10.61x
Twist Bioscience Corporation (TWST)vs ›	$10.40B	N/A	N/A	N/A	N/A
Bio-Techne Corporation (TECH)vs ›	$11.34B	46.60x	29.31x	24.60x	23.61x
Globus Medical, Inc. (GMED)vs ›	$10.31B	N/A	39.63x	39.63x	39.63x
Madrigal Pharmaceuticals, Inc. (MDGL)vs ›	$11.47B	-13.45x	258.14x	258.14x	258.14x
10x Genomics, Inc. (TXG)vs ›	$10.24B	N/A	N/A	N/A	N/A
Molina Healthcare, Inc. (MOH)vs ›	$10.19B	4.07x	9.27x	11.38x	10.77x
DaVita Inc. (DVA)vs ›	$11.58B	3.66x	4.05x	3.97x	4.62x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

BioMarin Pharmaceutical Inc. (BMRN)

$10.87B

48.95x

24.85x

23.88x

15.73x

The Cooper Companies, Inc. (COO)vs ›

$11.01B

6.83x

6.50x

6.73x

9.55x

Universal Health Services, Inc. (UHS)vs ›

$10.72B

12.68x

10.82x

8.80x

10.61x

Twist Bioscience Corporation (TWST)vs ›

$10.40B

N/A

Bio-Techne Corporation (TECH)vs ›

$11.34B

46.60x

29.31x

24.60x

23.61x

Globus Medical, Inc. (GMED)vs ›

$10.31B

N/A

39.63x

Madrigal Pharmaceuticals, Inc. (MDGL)vs ›

$11.47B

-13.45x

258.14x

10x Genomics, Inc. (TXG)vs ›

$10.24B

N/A

Molina Healthcare, Inc. (MOH)vs ›

$10.19B

4.07x

9.27x

11.38x

10.77x

DaVita Inc. (DVA)vs ›

$11.58B

3.66x

4.05x

3.97x

4.62x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The interest coverage ratio for BMRN stock is 48.95x.

Is BioMarin Pharmaceutical Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 48.95x is 211% above its 5-year average of 15.73x, around the middle of its 5-year range (-18.10x–103.35x).

What is the TTM average interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The TTM average interest coverage ratio for BMRN stock is 24.85x.

What is the 3Y average interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The 3Y average interest coverage ratio for BMRN stock is 23.88x.

What is the 5Y average interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The 5Y average interest coverage ratio for BMRN stock is 15.73x.

What is the 10Y average interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The 10Y average interest coverage ratio for BMRN stock is 3.56x.

What is the 15Y average interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The 15Y average interest coverage ratio for BMRN stock is -2.68x.

What is the 20Y average interest coverage ratio for BioMarin Pharmaceutical Inc. (BMRN)?

The 20Y average interest coverage ratio for BMRN stock is -2.48x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	1.75x
2026-03-31	8.67x
2025-12-31	28.58x
2025-09-30	-18.10x
2025-06-30	103.35x
2025-03-31	78.20x
2024-12-31	62.63x
2024-09-30	38.37x
2024-06-30	33.70x
2024-03-31	24.94x
2023-12-31	2.33x
2023-09-30	8.08x
2023-06-30	17.46x
2023-03-31	16.85x
2022-12-31	-6.76x
2022-09-30	-0.52x
2022-06-30	10.15x
2022-03-31	36.08x
2021-12-31	-17.13x
2021-09-30	-13.75x
2021-06-30	3.06x
2021-03-31	6.59x
2020-12-31	-9.44x
2020-09-30	-5.83x
2020-06-30	-5.09x
2020-03-31	15.18x
2019-12-31	-1.32x
2019-09-30	1.37x
2019-06-30	-6.02x
2019-03-31	-8.02x
2018-12-31	-4.92x
2018-09-30	-1.30x
2018-06-30	-2.07x
2018-03-31	-3.84x
2017-12-31	4.98x
2017-09-30	-1.26x
2017-06-30	-3.87x
2017-03-31	-2.00x
2016-12-31	-9.21x
2016-09-30	-6.02x
2016-06-30	-57.60x
2016-03-31	-8.22x
2015-12-31	10.86x
2015-09-30	-8.67x
2015-06-30	-6.43x
2015-03-31	-6.96x
2014-12-31	-6.39x
2014-09-30	1.23x
2014-06-30	-2.05x
2014-03-31	-2.91x
2013-12-31	-6.89x
2013-09-30	-96.43x
2013-06-30	-33.25x
2013-03-31	-19.08x
2012-12-31	-24.30x
2012-09-30	-5.71x
2012-06-30	-16.08x
2012-03-31	-11.23x
2011-12-31	-12.58x
2011-09-30	-6.38x
2011-06-30	0.37x
2011-03-31	1.07x
2010-12-31	-1.48x
2010-09-30	-0.64x
2010-06-30	1.15x
2010-03-31	1.15x
2009-12-31	2.35x
2009-09-30	3.52x
2009-06-30	0.98x
2009-03-31	-1.08x
2008-09-30	0.57x
2008-06-30	1.11x
2007-06-30	-3.66x
2006-12-31	-1.84x
2005-12-31	-4.49x
2005-06-30	-6.39x
2004-03-31	-14.10x
2003-12-31	-18.12x
2003-09-30	-14.74x
2002-12-31	-30.67x

DATE

INTEREST COVERAGE RATIO

2026-06-30

1.75x

2026-03-31

8.67x

2025-12-31

28.58x

2025-09-30

-18.10x

2025-06-30

103.35x

2025-03-31

78.20x

2024-12-31

62.63x

2024-09-30

38.37x

2024-06-30

33.70x

2024-03-31

24.94x

2023-12-31

2.33x

2023-09-30

8.08x

2023-06-30

17.46x

2023-03-31

16.85x

2022-12-31

-6.76x

2022-09-30

-0.52x

2022-06-30

10.15x

2022-03-31

36.08x

2021-12-31

-17.13x

2021-09-30

-13.75x

2021-06-30

3.06x

2021-03-31

6.59x

2020-12-31

-9.44x

2020-09-30

-5.83x

2020-06-30

-5.09x

2020-03-31

15.18x

2019-12-31

-1.32x

2019-09-30

1.37x

2019-06-30

-6.02x

2019-03-31

-8.02x

2018-12-31

-4.92x

2018-09-30

-1.30x

2018-06-30

-2.07x

2018-03-31

-3.84x

2017-12-31

4.98x

2017-09-30

-1.26x

2017-06-30

-3.87x

2017-03-31

-2.00x

2016-12-31

-9.21x

2016-09-30

-6.02x

2016-06-30

-57.60x

2016-03-31

-8.22x

2015-12-31

10.86x

2015-09-30

-8.67x

2015-06-30

-6.43x

2015-03-31

-6.96x

2014-12-31

-6.39x

2014-09-30

1.23x

2014-06-30

-2.05x

2014-03-31

-2.91x

2013-12-31

-6.89x

2013-09-30

-96.43x

2013-06-30

-33.25x

2013-03-31

-19.08x

2012-12-31

-24.30x

2012-09-30

-5.71x

2012-06-30

-16.08x

2012-03-31

-11.23x

2011-12-31

-12.58x

2011-09-30

-6.38x

2011-06-30

0.37x

2011-03-31

1.07x

2010-12-31

-1.48x

2010-09-30

-0.64x

2010-06-30

1.15x

2010-03-31

1.15x

2009-12-31

2.35x

2009-09-30

3.52x

2009-06-30

0.98x

2009-03-31

-1.08x

2008-09-30

0.57x

2008-06-30

1.11x

2007-06-30

-3.66x

2006-12-31

-1.84x

2005-12-31

-4.49x

2005-06-30

-6.39x

2004-03-31

-14.10x

2003-12-31

-18.12x

2003-09-30

-14.74x

2002-12-31

-30.67x

Interest Coverage Ratio: 48.95x

BMRN Interest Coverage Ratio

BMRN Average Interest Coverage Ratio Chart

BMRN Current vs Average Interest Coverage Ratio Chart

BMRN Interest Coverage Ratio Metrics

BMRN Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

BMRN Interest Coverage Ratio History

Related Metrics